Abstract | OBJECTIVE: METHODS: [C57BL/6 x DBA/2]F1 mice inoculated with 5 x 10(7) DBA/2 spleen cells developed a variety of immunostimulatory symptoms, including the hyperproduction of anti-dsDNA antibodies and severe glomerulonephritis. Anti- alpha beta TCR Mab was injected intraperitoneally at a dose of 400 micrograms either on Day 2 or Day 21, followed 5 days later by another administration of 200 micrograms. RESULTS: Short term treatment with anti- alpha beta TCR Mab starting 2 days after cell transfer markedly reduced the serum anti-dsDNA antibody ( IgG) titers and virtually abolished the induction of glomerulonephritis. Anti- alpha beta TCR treatment begun on Day 21 was also found effective in preventing the development of glomerulonephritis. In this case, however, the serum anti-dsDNA IgG titers were not significantly reduced compared with untreated GVHD controls. Immunohistochemical staining of the kidney with antimouse IgG + IgM detected no antibody deposition in the glomerulus either in the mice given delayed anti- alpha beta TCR treatment or in the mice treated prophylactically with anti- alpha beta TCR Mab, despite the high titers of serum anti-dsDNA IgG observed in the former group. In contrast, massive antibody deposition was regularly detectable in the glomerulus of the untreated GVHD controls. CONCLUSION: Our report demonstrates the therapeutic potential of anti- alpha beta TCR Mab for lupus-like disease, while suggesting that some help from cellular immunity is likely required for the hyperproduced autoantibodies to become deposited in the glomerulus in this model.
|
Authors | T Maeda, K Nomoto |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 22
Issue 12
Pg. 2259-65
(Dec 1995)
ISSN: 0315-162X [Print] Canada |
PMID | 8835559
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Antinuclear
- Antibodies, Monoclonal
- Immunoglobulin G
- Receptors, Antigen, T-Cell
- DNA
|
Topics |
- Animals
- Antibodies, Antinuclear
(blood)
- Antibodies, Monoclonal
(pharmacology, therapeutic use)
- DNA
(immunology)
- Female
- Glomerulonephritis
(immunology, prevention & control)
- Graft vs Host Disease
(immunology, prevention & control)
- Immunoenzyme Techniques
- Immunoglobulin G
(blood, drug effects)
- Kidney
(drug effects, immunology, pathology)
- Lupus Nephritis
(immunology, prevention & control)
- Mice
- Mice, Inbred C57BL
- Mice, Inbred DBA
- Proteinuria
(drug therapy, prevention & control)
- Receptors, Antigen, T-Cell
(antagonists & inhibitors)
- Spleen
(cytology, immunology)
|